Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN

Overview | Financials
Company Name Regeneron Pharmaceuticals, Inc.
Symbol REGN
Currency USD
Price 558.44
Market Cap 58,172,694,800
Dividend Yield 0%
52-week-range 476.49 - 1,170.58
Industry Biotechnology
Sector Healthcare
CEO Dr. Leonard S. Schleifer M.D., Ph.D.
Website https://www.regeneron.com

An error occurred while fetching data.

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following

Related Stocks

Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

ISRG

470 USD

Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILD

115.88 USD

Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

VRTX

395.25 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

24.83 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

98.18 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.98 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

652.83 USD

Biogen Inc. logo

Biogen Inc.

BIIB

141.35 USD

Financials

Numbers are in millions USD

Numbers are in millions USD